RankAlpha logo
Back to Rankings

AKTX

Akari TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AKTX vs peer average
42/100
AKTX vs. peer average (D vs. C)
Grade spread
A 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

GTBP is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $16.85M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGTBPGT Biopharma
AKTX
Akari Therapeutics
GTBP
GT Biopharma
Grade
D
D
Momentum
38
48
Value
42
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs GTBP

AKTX / GTBP
Grade Position
Below peers
AKTX vs. peer average (D vs. C)
42/100
Momentum
38
GTBP
Value
42
AKTX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKTX
1
GTBP
GT Biopharma Inc Common
D
40/100
Even
2
CTXR
Citius Pharmaceuticals Inc Common
F
20/100
+1
3
QNCX
Quince Therapeutics Inc Common
C
60/100
-1
4
HIND
Vyome Holdings Inc Common
F
20/100
+1
5
NCEL
NewcelX Ltd Common
F
20/100
+1
GTBP is the first peer returned for this comparison set.